Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Emerging Nosocomial Pathogen Isolated from Prosthetic Joint Infections

By LabMedica International staff writers
Posted on 10 Jan 2017
Further knowledge about the clinical and microbiological characteristics of prosthetic joint infections (PJIs) caused by different coagulase-negative staphylococci (CoNS) may facilitate interpretation of microbiological findings and improve treatment algorithms.

The implementations of new methods, such as matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) or real-time broad-range polymerase chain reaction (PCR), has simplified the identification of CoNS to the species level.

A team of Swedish scientists working with those at the Linköping University (Sweden) performed retrospective cohort study included three centres and 21 patients with significant growth of Staphylococcus capitis during revision surgery for PJI between 2005 and 2014. More...
Clinical data were extracted and further microbiological characterisation of the S. capitis isolates was performed.

CoNS isolated in equal to or greater than two perioperative tissue samples obtained from revision surgery for hip or knee arthroplasties due to PJI were included for further analysis. If there were not at least two CoNS isolates with similar colony morphology and antimicrobial resistance pattern, the patient was excluded. MALDI-TOF MS was performed for species identification using a Microflex LT (Bruker Daltonik GmbH, Bremen, Germany).

To discriminate between the subspecies of S. capitis, urease activity and maltose fermentation tests were performed, using both tube test and API-ID32 STAPH (bioMérieux, Marcy l’Etoile, France). Standard antibiotic susceptibility testing by the disc diffusion test was also performed. The bioMérieux DiversiLab semi-automatic repetitive sequence-based PCR microbial genotyping system was used to detect the genomic fingerprints of each S. capitis isolate.

Ten patients experienced monomicrobial infections and among patients available for evaluation, 86% of chronic infections and 70% of early post-interventional infections achieved clinical cure; 90 % of monomicrobial infections remained infection-free. Multidrug-resistant S. capitis was detected in 28.6 % of isolates, methicillin resistance in 38.1 % and fluoroquinolone resistance in 14.3 %, but no isolates were rifampin-resistant. Heterogeneous glycopeptide-intermediate resistance was detected in 38.1 % and biofilm-forming ability was common.

The authors concluded that Staphylococcus capitis has the potential to cause PJIs, with infection most likely being contracted during surgery or in the early postoperative period. As S. capitis might be an emerging nosocomial pathogen, surveillance of the prevalence of PJIs caused by S. capitis could be recommended. The study was published in the January 2017 issue of the European Journal of Clinical Microbiology & Infectious Diseases.

Related Links:
Linköping University
Bruker Daltonik
bioMérieux

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.